Last reviewed · How we verify

NCT06656819: TMSpine

The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity

Recruiting now Last updated 30 March 2026
What this trial tests

trial testing Magstim Rapid2 in Healthy in 50 participants. Currently enrolling.

Timeline
1 July 2020
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorUniversity of Texas Southwestern Medical Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date1 July 2020
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 18 to 39, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this project is to test our central hypothesis that the spinal cord neuroplasticity in females will be modulated by the level of estradiol concentration. under aim 1 we will determine the influence of estradiol fluctuations on spinal circuit excitability post afferent (sensory) mediated subthreshold motor priming in young healthy females and males. We will use an established repetitive peripheral nerve electrical stimulation with a stimulation intensity below the motor threshold to prime the spinal motor circuits. under aim 2 we seek to characterize the input output property of spinal circuit excitability after descending drive (motor) mediated priming in young healthy male participants. in aim 3 we will examine the influence of estradiol fluctuations on descending drive mediated motor priming in young healthy females.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Magstim Rapid2

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06656819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing